Inflexion exits Pharmaspectra
Pharmaspectra's sale is Inflexion’s fourth to a US-listed buyer in the last 12 months.
Pharmaspectra's sale is Inflexion’s fourth to a US-listed buyer in the last 12 months.
Copyright PEI Media
Not for publication, email or dissemination
